ELZASONAN

ELZASONAN Chemische Eigenschaften,Einsatz,Produktion Methoden

• Verwenden

  Elzasonan is a selective 5-hydroxytryptamine 1B receptor antagonist that was developed by Pfizer (and then later discontinued in 2008) to treat patients with major depressive disorder and obsessive compulsive disorder.

ELZASONAN Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(3)Suppliers